Epic Bio specializes in modulating gene expression in vivo. It developed the Gene Expression Modulation System, the most extensive known collection of modulators that will be used to design guide RNAs specialized in targeted genes, according to a July 12 company news release.
Epic Bio founder Stanley Qi, PhD, is co-inventor on the CRISPR patent held by the University of California. Dr. Qi’s background in epigenetics and CRISPR led him to found Epic Bio.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
